Thomas G. Pretlow

5.1k total citations
82 papers, 4.0k citations indexed

About

Thomas G. Pretlow is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Thomas G. Pretlow has authored 82 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 25 papers in Pulmonary and Respiratory Medicine and 22 papers in Oncology. Recurrent topics in Thomas G. Pretlow's work include Prostate Cancer Treatment and Research (21 papers), Microfluidic and Bio-sensing Technologies (10 papers) and Genetic factors in colorectal cancer (8 papers). Thomas G. Pretlow is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Microfluidic and Bio-sensing Technologies (10 papers) and Genetic factors in colorectal cancer (8 papers). Thomas G. Pretlow collaborates with scholars based in United States, Switzerland and Norway. Thomas G. Pretlow's co-authors include Theresa P. Pretlow, Johng S. Rhim, Charles W. Boone, Frank S. French, James L. Mohler, Christopher W. Gregory, Stuart Schwartz, Saeid B. Amini, Man‐Sun Sy and Katherine G. Hamil and has published in prestigious journals such as Science, Nature Genetics and The Journal of Immunology.

In The Last Decade

Thomas G. Pretlow

82 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas G. Pretlow United States 33 1.8k 1.5k 919 716 630 82 4.0k
Herbert K. Oie United States 33 2.1k 1.2× 888 0.6× 1.4k 1.5× 600 0.8× 807 1.3× 71 4.4k
Ming‐Fong Lin United States 37 2.5k 1.4× 1.6k 1.0× 938 1.0× 748 1.0× 567 0.9× 100 4.1k
Scott D. Cramer United States 35 1.6k 0.9× 924 0.6× 677 0.7× 788 1.1× 504 0.8× 72 3.3k
Adrie van Bokhoven United States 35 2.5k 1.3× 1.6k 1.0× 992 1.1× 1.1k 1.5× 356 0.6× 74 4.6k
Pernilla Wikström Sweden 38 2.3k 1.2× 1.9k 1.2× 1.1k 1.2× 1.3k 1.8× 374 0.6× 105 4.5k
Pradip K. Majumder United States 27 4.1k 2.2× 1.0k 0.7× 1.4k 1.5× 1.0k 1.5× 289 0.5× 78 5.7k
Zhiyong Guo China 39 2.3k 1.3× 1.7k 1.1× 818 0.9× 1.1k 1.5× 897 1.4× 126 5.6k
Theresa P. Pretlow United States 36 3.4k 1.8× 1.3k 0.8× 2.1k 2.3× 1.1k 1.6× 908 1.4× 84 6.6k
Alfonso Calvo Spain 40 2.4k 1.3× 875 0.6× 1.5k 1.7× 1.0k 1.5× 281 0.4× 198 5.0k
Francesca Pentimalli Italy 38 2.3k 1.2× 429 0.3× 1.1k 1.2× 922 1.3× 444 0.7× 120 3.8k

Countries citing papers authored by Thomas G. Pretlow

Since Specialization
Citations

This map shows the geographic impact of Thomas G. Pretlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Pretlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Pretlow more than expected).

Fields of papers citing papers by Thomas G. Pretlow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas G. Pretlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Pretlow. The network helps show where Thomas G. Pretlow may publish in the future.

Co-authorship network of co-authors of Thomas G. Pretlow

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Pretlow. A scholar is included among the top collaborators of Thomas G. Pretlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Pretlow. Thomas G. Pretlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fei, Baowei, Hesheng Wang, Xiang Chen, et al.. (2007). In vivo small animal imaging for early assessment of therapeutic efficacy of photodynamic therapy for prostate cancer. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 6511. 651102–651102. 5 indexed citations
2.
Luo, Liping, et al.. (2006). Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer. Carcinogenesis. 27(6). 1153–1159. 34 indexed citations
3.
Whitehurst, Garnett B., et al.. (2006). Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma. Cancer. 52(1). 155–160. 1 indexed citations
4.
Pretlow, Theresa P. & Thomas G. Pretlow. (2005). Mutant KRAS in aberrant crypt foci (ACF): Initiation of colorectal cancer?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1756(2). 83–96. 77 indexed citations
5.
Pretlow, Theresa P., Winfried Edelmann, Raju Kucherlapati, Thomas G. Pretlow, & Leonard H. Augenlicht. (2003). Spontaneous Aberrant Crypt Foci in Apc1638N Mice with a Mutant Apc Allele. American Journal Of Pathology. 163(5). 1757–1763. 18 indexed citations
6.
Korkmaz, Kemal, Ceren Gönen Korkmaz, Thomas G. Pretlow, & Fahri Saatcioglu. (2001). Distinctly Different Gene Structure of KLK4/KLK-L1 /Prostase/ARM1 Compared with Other Members of the Kallikrein Family: Intracellular Localization, Alternative cDNA Forms, and Regulation by Multiple Hormones. DNA and Cell Biology. 20(7). 435–445. 38 indexed citations
7.
Korkmaz, Kemal, et al.. (2000). An Efficient Procedure for Cloning Hormone-Responsive Genes from a Specific Tissue. DNA and Cell Biology. 19(8). 499–506. 15 indexed citations
8.
Gregory, Christopher W., Desok Kim, Ping Ye, et al.. (1999). Androgen Receptor Up-Regulates Insulin-Like Growth Factor Binding Protein-5 (IGFBP-5) Expression in a Human Prostate Cancer Xenograft*. Endocrinology. 140(5). 2372–2381. 56 indexed citations
9.
Gumerlock, Paul H., et al.. (1999). Overexpression of cyclin D1 is rare in human prostate carcinoma. The Prostate. 38(1). 40–45. 47 indexed citations
10.
Stearns, Mark E., Joy L. Ware, David B. Agus, et al.. (1998). Workgroup 2: Human xenograft models of prostate cancer. The Prostate. 36(1). 56–58. 14 indexed citations
11.
Tan, Jiann-an, Yousuf Sharief, Katherine G. Hamil, et al.. (1997). Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells. Molecular Endocrinology. 11(4). 450–459. 288 indexed citations
12.
Grasso, Adam W., Duanzhi Wen, C. Miller, et al.. (1997). ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene. 15(22). 2705–2716. 126 indexed citations
13.
Nagabhushan, M., et al.. (1996). Altered Expression of CD44 in Human Prostate Cancer During Progression. American Journal of Clinical Pathology. 106(5). 647–651. 58 indexed citations
14.
Pretlow, Thomas G., et al.. (1995). Organ culture of benign, aging, and hyperplastic human prostate. Microscopy Research and Technique. 30(4). 271–281. 10 indexed citations
15.
Pretlow, Theresa P., et al.. (1992). Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis. 13(9). 1509–1512. 250 indexed citations
16.
Bostwick, David G., Rodolfo Montironi, Thomas G. Pretlow, et al.. (1992). Current and proposed biologic markers in prostate cancer. Journal of Cellular Biochemistry. 50(S16H). 65–67. 14 indexed citations
17.
Pretlow, Thomas G., Bin Yang, Charlotte S. Kaetzel, et al.. (1991). Tissue concentrations of prostate‐specific antigen in prostatic carcinoma and benign prostatic hyperplasia. International Journal of Cancer. 49(5). 645–649. 52 indexed citations
18.
Rackley, Raymond R., Edwin L. Bradley, Howard S. Levin, et al.. (1990). Enzymatic activities in extracts of small (20 ± 5 mg) samples of prostatic carcinoma. Analytical Biochemistry. 184(1). 128–134. 3 indexed citations
19.
Pearson, Jeffrey P., et al.. (1989). Beta-glucuronidase activity in prostatic carcinoma and benign prostatic hyperplasia. Cancer. 64(4). 911–915. 10 indexed citations
20.
Pretlow, Thomas G. & Theresa P. Pretlow. (1979). Cell Electrophoresis. International review of cytology. 61. 85–128. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herbert K. Oie Breakdown of academic impact, for papers by Ming‐Fong Lin Breakdown of academic impact, for papers by Scott D. Cramer Breakdown of academic impact, for papers by Adrie van Bokhoven Breakdown of academic impact, for papers by Pernilla Wikström Breakdown of academic impact, for papers by Pradip K. Majumder Breakdown of academic impact, for papers by Zhiyong Guo Breakdown of academic impact, for papers by Theresa P. Pretlow Breakdown of academic impact, for papers by Alfonso Calvo Breakdown of academic impact, for papers by Francesca Pentimalli
Rankless by CCL
2026